These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 8049437

  • 1. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
    Bradstock K, Matthews J, Benson E, Page F, Bishop J.
    Blood; 1994 Aug 15; 84(4):1220-5. PubMed ID: 8049437
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD.
    Blood; 1995 Oct 15; 86(8):3097-108. PubMed ID: 7579404
    [Abstract] [Full Text] [Related]

  • 3. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 15; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar 15; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 15; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N.
    Leukemia; 1992 May 15; 6(5):393-9. PubMed ID: 1375696
    [Abstract] [Full Text] [Related]

  • 10. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M.
    Leuk Res; 1996 May 15; 20(11-12):983-5. PubMed ID: 9009257
    [Abstract] [Full Text] [Related]

  • 11. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
    Dunphy CH, Tang W.
    Arch Pathol Lab Med; 2007 May 15; 131(5):748-54. PubMed ID: 17488160
    [Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrózek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD.
    Leukemia; 1998 Mar 15; 12(3):317-25. PubMed ID: 9529125
    [Abstract] [Full Text] [Related]

  • 13. Immunophenotyping is an independent factor for risk stratification in AML.
    Repp R, Schaekel U, Helm G, Thiede C, Soucek S, Pascheberg U, Wandt H, Aulitzky W, Bodenstein H, Sonnen R, Link H, Ehninger G, Gramatzki M, AML-SHG Study Group.
    Cytometry B Clin Cytom; 2003 May 15; 53(1):11-9. PubMed ID: 12717686
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.
    Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, Arceci RJ, Woods WG, Loken MR.
    Blood; 2003 May 01; 101(9):3398-406. PubMed ID: 12506020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR, Zhu HH, Ruan GR, Qin YZ, Shi HX, Lai YY, Chang Y, Wang YZ, Lu D, Hao L, Li JL, Li LD, Jiang B, Huang XJ.
    Leuk Res; 2013 Jul 01; 37(7):737-41. PubMed ID: 23601747
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
    Kristensen JS, Hokland P.
    Leuk Res; 1991 Jul 01; 15(8):693-700. PubMed ID: 1895750
    [Abstract] [Full Text] [Related]

  • 19. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
    Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, Civin CI.
    Br J Haematol; 1990 Nov 01; 76(3):340-7. PubMed ID: 1702006
    [Abstract] [Full Text] [Related]

  • 20. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
    Chang H, Salma F, Yi QL, Patterson B, Brien B, Minden MD.
    Leuk Res; 2004 Jan 01; 28(1):43-8. PubMed ID: 14630079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.